This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Key performance metrics for wide market index funds in retirement include return consistency, volatility, and cost efficiency to monitor progress.
28,290 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A new wave of small modular reactors could reshape the US power mix. This article explains why NuScale Power is catch...
Cardano’s May 29 hard fork vote is unfolding as a practical test of governance and DeFi activity. Key infrastructure ...
A single conference-call moment changed the mood around Eli Lilly. By unpacking eight key themes from the CEO, invest...
A pipeline powerhouse with a 6% payout has drawn fresh attention as inflation-linked cash flows and fixed-fee contrac...
Wall Street is split on two big AI chips players: Intel and Marvell. One stock is riding optimism about data-center d...
In 2026, Nike faces a pivotal test beyond revenue growth. This article explains why nike's most important question ce...
A new NBER study ties political promises about loan forgiveness to bigger defaults and altered spending, underscoring...
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Argus boosts Exxon Mobil's target to $169, signaling confidence in higher 2026 output from Permian and Guyana and a r...
Singapore's companies dominate the Southeast Asia 500 by revenue, capturing roughly a third of the region's total. Th...
A contractor seeks over $1 million in damages from Kanye West over renovations at his Malibu beach house. The civil t...